Updated recommendations for the treatment of rheumatoid arthritis: another step on a long road
- PMID: 22473919
- PMCID: PMC4097090
- DOI: 10.1002/acr.21659
Updated recommendations for the treatment of rheumatoid arthritis: another step on a long road
Comment on
-
2012 update of the 2008 American College of Rheumatology recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis.Arthritis Care Res (Hoboken). 2012 May;64(5):625-39. doi: 10.1002/acr.21641. Arthritis Care Res (Hoboken). 2012. PMID: 22473917 Free PMC article. Review. No abstract available.
Similar articles
-
Level of the indication of biologic agents in the 2012 American College of Rheumatology recommendations for the treatment of rheumatoid arthritis: comment on the article by Singh et al.Arthritis Care Res (Hoboken). 2013 May;65(5):832. doi: 10.1002/acr.21873. Arthritis Care Res (Hoboken). 2013. PMID: 23097263 No abstract available.
-
2012 update of the 2008 American College of Rheumatology recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis.Arthritis Care Res (Hoboken). 2012 May;64(5):625-39. doi: 10.1002/acr.21641. Arthritis Care Res (Hoboken). 2012. PMID: 22473917 Free PMC article. Review. No abstract available.
-
Reply: To PMID 22473917.Arthritis Care Res (Hoboken). 2013 May;65(5):832-3. doi: 10.1002/acr.21872. Arthritis Care Res (Hoboken). 2013. PMID: 23097242 No abstract available.
-
Oral glucocorticoids should be included in any recommendation for the use of nonbiologic and biologic disease-modifying antirheumatic drugs in the treatment of rheumatoid arthritis: comment on the article by Singh et al.Arthritis Care Res (Hoboken). 2012 Oct;64(10):1622-3; author reply 1623-4. doi: 10.1002/acr.21809. Arthritis Care Res (Hoboken). 2012. PMID: 23024030 No abstract available.
-
Rheumatology practice in Japan: challenges and opportunities.Rheumatol Int. 2019 Sep;39(9):1499-1505. doi: 10.1007/s00296-019-04281-0. Epub 2019 Mar 19. Rheumatol Int. 2019. PMID: 30888472 Review.
Cited by
-
A phase Ib multiple ascending dose study evaluating safety, pharmacokinetics, and early clinical response of brodalumab, a human anti-IL-17R antibody, in methotrexate-resistant rheumatoid arthritis.Arthritis Res Ther. 2013 Oct 25;15(5):R164. doi: 10.1186/ar4347. Arthritis Res Ther. 2013. PMID: 24286136 Free PMC article. Clinical Trial.
-
DEK-targeting DNA aptamers as therapeutics for inflammatory arthritis.Nat Commun. 2017 Feb 6;8:14252. doi: 10.1038/ncomms14252. Nat Commun. 2017. PMID: 28165452 Free PMC article.
-
Involvement of Multiple Transporters-mediated Transports in Mizoribine and Methotrexate Pharmacokinetics.Pharmaceuticals (Basel). 2012 Aug 10;5(8):802-36. doi: 10.3390/ph5080802. Pharmaceuticals (Basel). 2012. PMID: 24280676 Free PMC article.
-
Efficacy and safety of monoclonal antibodies targeting interleukin-17 pathway for inflammatory arthritis: a meta-analysis of randomized controlled clinical trials.Drug Des Devel Ther. 2016 Sep 9;10:2771-2777. doi: 10.2147/DDDT.S91374. eCollection 2016. Drug Des Devel Ther. 2016. PMID: 27672309 Free PMC article.
-
Safety, tolerability, pharmacokinetics, pharmacodynamics, and efficacy of WBP216, a novel IL-6 monoclonal antibody, in patients with rheumatoid arthritis: A phase Ia randomized placebo-controlled study.Front Immunol. 2023 Feb 28;13:1110992. doi: 10.3389/fimmu.2022.1110992. eCollection 2022. Front Immunol. 2023. PMID: 36926529 Free PMC article. Clinical Trial.
References
-
- Saag KG, Teng GG, Patkar NM, Anuntiyo J, Finney C, Curtis JR, et al. American College of Rheumatology 2008 recommendations for the use of nonbiologic and biologic disease-modifying antirheumatic drugs in rheumatoid arthritis. Arthritis Rheum. 2008;59(6):762–784. - PubMed
-
- Shekelle P. The appropriateness method. Med Decis Making. 2004;24(2):228–231. - PubMed
-
- Brott TG, Halperin JL, Abbara S, Bacharach JM, Barr JD, Bush RL, et al. ASA/ACCF/AHA/AANN/AANS/ACR/ASNR/CNS/SAIP/ SCAI/SIR/SNIS/SVM/SVS guideline on the management of patients with extracranial carotid and vertebral artery disease: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, and the American Stroke Association, American Association of Neuroscience Nurses, American Association of Neurological Surgeons, American College of Radiology, American Society of Neuroradiology, Congress of Neurological Surgeons, Society of Atherosclerosis Imaging and Prevention, Society for Cardiovascular Angiography and Interventions, Society of Interventional Radiology, Society of NeuroInterventional Surgery, Society for Vascular Medicine, and Society for Vascular Surgery. Vasc Med. 2011;16(1):35–77. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical